Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Vermeulens Releases Q3-2021 Market Outlook
Vermeulens has released its market outlook report for the third quarter of 2021. Key points include:
Towson University Begins Construction on College of Health Professions
Towson University began construction in October of 2021 on the $175 million College of Health Professions in Towson, Md. Designed by Perkins&Will and JMT Architecture, the 240,000-sf facility will accommodate growing programs in nursing, health sciences, occupational therapy, occupational science, and speech-language pathology and audiology.
University of Vermont Constructs Firestone Medical Research Building
The University of Vermont is building the $45 million Firestone Medical Research Building in Burlington. Designed by Payette and Black River Design, the collaborative 62,250-sf structure will provide the Larner College of Medicine with core facilities, flexible labs, conference rooms, and support spaces.
University of Pittsburgh at Greensburg Breaks Ground on Life Sciences Building
The University of Pittsburgh at Greensburg broke ground on the $19.2 million Life Sciences Building in August of 2021. Accommodating programs in nursing, allied health, biochemistry, and natural sciences, the 32,000-sf facility will provide sophisticated simulation suites, chemistry and biology labs, a telemedicine center, a clinical training lab, a computer lab, student lounges, and administrative space.
Howard University Plans National Research Center for Health Disparities
Howard University will begin construction in 2023 on the National Research Center for Health Disparities in Washington. Accelerating the discovery of new solutions for chronic illnesses, the 260,000-sf facility will provide sophisticated laboratory and office environments where academic investigators can engage in collaborative discovery with pharmaceutical companies and biomedical research organizations.